病理検査室市場の規模、シェア、動向分析レポート：タイプ別（病院ベース）、検査サービス別（一般生理検査、臨床検査）、エンドユーザー別（医師紹介）、地域別、セグメント別予測、2022年～2030年

病理検査室市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の病理検査室市場は2030年までに6122億米ドルに達すると予測されています。同市場は2022年から2030年にかけてCAGR7.86%で拡大すると予測されています。業界を牽引する主な要因としては、平均寿命の伸び、発展途上国のヘルスケアインフラの整備、診療報酬の優遇、定期検診の需要増などが挙げられます。

また、技術の進歩は診断のダイナミクスを変化させています。革新的な技術により、Point of Care Testing（POCT）デバイスが携帯可能になり、サンプリング技術が改善されたことで、診断サービスがより身近で効率的なものとなっています。いくつかの進歩は、品質、スピード、効率、拡張性によって患者ケアを方向付けることで、業界を変革すると期待されています。ヘルスケアシステムは、病理・診断ラボがより優れた臨床的意思決定エンジンとなり、医師が推論や診断、患者のモニタリングをより迅速かつ正確に行えるように支援することの重要性を徐々に強調しています。

COVID-19のパンデミックは、COVID-19の検査がパンデミック中に必要だったため、病理/診断ラボの需要が高くなっています。COVID-19感染の急増は、資金調達と検査の増加をもたらし、市場全体の成長を後押ししています。例えば、米国の（NIH）国立衛生研究所は2020年9月に、地域の診断を後押しするイニシアチブの一環として、新しいCOVID-19検査技術のセットへの製造支援のスケールアップのために、Maxim Biomedical Inc、MatMaCorp、 MicroGEM Internationalなど9団体に1億2,930万米ドルを助成すると発表しました。

病理検査室市場レポートハイライト

タイプ別では、2021年の間、病院ベースの診断ラボが市場を独占しました。これは、病院で利用できる高度な検査が、複雑な診断のための唯一の最適なソリューションとなっていることに起因しています

イメージング＆放射線検査分野は、イメージング技術の進歩、世界の事故や対象疾患の高い有病率により、予測期間中に最も速い成長を遂げると予想されます。

エンドユーザー別では、2021年に医師による紹介が市場を独占しました。個人の健康と幸福を監視するための自己認識の増加により、ウォークインと法人顧客が有利な成長を遂げると予想される

米国は、米国で最も顕著な疾患であることから、心血管の健康状態の診断に高い需要が見込まれる

欧州は、予測期間中、腫瘍検査に対する高い需要が見込まれます。デンマークは、世界がん研究基金インターナショナルによるがんの有病率で世界一です。

市場は最近、サービスの付加価値向上＆研究拡大を目指す主要プレーヤーによる複数の共同研究を行っています。例えば、2022年7月、ユニラボは、Subtle Medicalとの提携を発表し、同社のAIベースのMRI技術を採用し、高品質で迅速なMRIを実現する最初の診断会社となることを発表しました。このソリューションは、まずスウェーデンで発売される予定です。

目次

第1章 調査手法と範囲

• 地域範囲
• 調査手法
  • 情報調達
    • 購入したデータベース
    • GVRの内部データベース
    • 二次情報
    • 1次調査
    • 1次調査の内容
• 情報またはデータ分析
  • データ分析モデル
• 市場の策定と検証
• モデルの詳細
  • コモディティフロー分析
  • ボリューム価格分析
• 二次情報一覧
• 略語一覧
• 目的

第2章 エグゼクティブサマリー

• 市場の見通し
• セグメントの見通し
• 地域の見通し
• 競合考察

第3章 市場変数、動向、範囲

• 市場力学
  • 市場促進要因分析
    • 新興諸国におけるヘルスケアインフラの改善
    • 定期健康診断の需要増
    • 診断サービスに対するガウンの払い戻し
  • 市場抑制要因分析
    • ハイエンドの分子診断の手頃な価格
    • 熟練した労働力の不足。
• ビジネス環境分析ツール
  • ポーターのファイブフォース分析
    • 新規参入業者の脅威
    • 買い手の交渉力
    • 競争企業間の敵対関係
    • 代替品の脅威
    • 供給企業の交渉力
• COVID-19の影響
• 規制の枠組みと償還のシナリオ

第4章 病理検査室市場：タイプ分析

• タイプ別の病理学研究所の市場シェア分析、2021年および2030年
• セグメントダッシュボード
• タイプの市場規模と予測および傾向分析、2017年から2030年
  • 病院ベース
  • スタンドアロンラボ
  • 診断チェーン

第5章 病理検査室市場：検査サービス分析

• 病理学研究所試験サービス市場シェア分析、2021年および2030年
• セグメントダッシュボード
• テストサービスの市場規模と予測、およびトレンド分析、2017年から2030年：
  • 一般的な生理学的および臨床的検査
  • 画像検査と放射線検査
  • 難解なテスト
  • COVID-19テスト

第6章 病理検査室市場：エンドユース分析

• Pathology Laboratoriesの最終用途市場シェア分析、2021年および2030年
• セグメントダッシュボード
• 次の最終用途の市場規模と予測、およびトレンド分析、2017年から2030年
  • 医師の紹介
  • ウォークイン
  • コーポレート

第7章 病理検査室市場：地域分析

• 病理学研究所の地域市場シェア分析、2021年および2030年
• 地域市場のスナップショット（市場規模、 CAGR）
• 市場規模、予測、トレンド分析、2017年から2030年
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • スペインの病理検査室市場、2017年から203年（10億米ドル）
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東とアフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第8章 競合分析

• 主要な市場参入企業別最近の動向と影響分析
• 競合の分類（主要なイノベーター、市場のリーダー、新興企業）
• 企業プロファイル
  • Quest Diagnostics Incorporated
    • 会社概要
    • 財務実績
    • サービスのベンチマーク
    • 戦略的イニシアチブ
  • Eurofins Scientific
    • 会社概要
    • 財務実績
    • サービスのベンチマーク
    • 戦略的イニシアチブ
  • Laboratory Corporation of America Holdings
    • 会社概要
    • 財務実績
    • サービスのベンチマーク
    • 戦略的イニシアチブ
  • Exact Sciences Laboratories LLC
    • 会社概要
    • 財務実績
    • サービスのベンチマーク
    • 戦略的イニシアチブ
  • Spectra Laboratories
    • 会社概要
    • 財務実績
    • サービスのベンチマーク
    • 戦略的イニシアチブ
  • SYNLAB International GmbH
    • 会社概要
    • 財務実績
    • サービスのベンチマーク
    • 戦略的イニシアチブ
  • Sonic Healthcare Limited
    • 会社概要
    • 財務実績
    • サービスのベンチマーク
    • 戦略的イニシアチブ
  • DR Lal Path Labs.
    • 会社概要
    • 財務実績
    • サービスのベンチマーク
    • 戦略的イニシアチブ
  • Metropolis Healthcare
    • 会社概要
    • 財務実績
    • サービスのベンチマーク
    • 戦略的イニシアチブ
  • Kingmed Diagnostics
    • 会社概要
    • 財務実績
    • サービスのベンチマーク
    • 戦略的イニシアチブ
  • Healius Limited
    • 会社概要
    • 財務実績
    • サービスのベンチマーク
    • 戦略的イニシアチブ
  • BioReference
    • 会社概要
    • 財務実績
    • サービスのベンチマーク
    • 戦略的イニシアチブ
  • Centro de Diagnosticos
    • 会社概要
    • 財務実績
    • サービスのベンチマーク
    • 戦略的イニシアチブ
  • Falco Holdings
    • 会社概要
    • 財務実績
    • サービスのベンチマーク
    • 戦略的イニシアチブ
  • Unilabs
    • 会社概要
    • 財務実績
    • サービスのベンチマーク
    • 戦略的イニシアチブ
• ベンダー情勢
  • Major Deals &Strategic Alliances
  • 会社の市況分析

List of Tables

• TABLE 1 List of secondary sources
• TABLE 2 List of abbreviations
• TABLE 3 Global pathology laboratories market, by Region, 2017 - 2030 (USD Billion)
• TABLE 4 Global pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 5 Global pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 6 Global pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 7 North America pathology laboratories market, by Country, 2017 - 2030 (USD Billion)
• TABLE 8 North America pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 9 North America pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 10 North America pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 11 U.S. pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 12 U.S. pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 13 U.S. pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 14 Canada pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 15 Canada pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 16 Canada pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 17 Europe pathology laboratories market, by Country, 2017 - 2030 (USD Billion)
• TABLE 18 Europe pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 19 Europe pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 20 Europe pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 21 UK pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 22 UK pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 23 UK pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 24 Germany pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 25 Germany pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 26 Germany pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 27 France pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 28 France pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 29 France pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 30 Italy pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 31 Italy pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 32 Italy pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 33 Spain pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 34 Spain pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 35 Spain pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 36 Rest of Europe pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 37 Rest of Europe pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 38 Rest of Europe pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 39 Asia Pacific pathology laboratories market, by Country, 2017 - 2030 (USD Billion)
• TABLE 40 Asia Pacific pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 41 Asia Pacific pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 42 Asia Pacific pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 43 China pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 44 China pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 45 China pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 46 Japan pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 47 Japan pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 48 Japan pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 49 India pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 50 India pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 51 India pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 52 South Korea pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 53 South Korea pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 54 South Korea pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 55 Australia pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 56 Australia pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 57 Australia pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 58 Rest of Asia Pacific pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 59 Rest of Asia Pacific pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 60 Rest of Asia Pacific pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 61 Latin America pathology laboratories market, by Country, 2017 - 2030 (USD Billion)
• TABLE 62 Latin America pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 63 Latin America pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 64 Latin America pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 65 Brazil pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 66 Brazil pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 67 Brazil pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 68 Mexico pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 69 Mexico pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 70 Mexico pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 71 Argentina pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 72 Argentina pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 73 Argentina pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 74 Rest of Latin America pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 75 Rest of Latin America pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 76 Rest of Latin America pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 77 Middle East & Africa pathology laboratories market, by Country, 2017 - 2030 (USD Billion)
• TABLE 78 Middle East & Africa pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 79 Middle East & Africa pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 80 Middle East & Africa pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 81 South Africa pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 82 South Africa pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 83 South Africa pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 84 Saudi Arabia pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 85 Saudi Arabia pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 86 Saudi Arabia pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 87 UAE pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 88 UAE pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 89 UAE pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)
• TABLE 90 Rest of Middle East & Africa pathology laboratories market, by Type, 2017 - 2030 (USD Billion)
• TABLE 91 Rest of Middle East & Africa pathology laboratories market, by Testing Services, 2017 - 2030 (USD Billion)
• TABLE 92 Rest of Middle East & Africa pathology laboratories market, by End Use, 2017 - 2030 (USD Billion)

List of Figures

• FIG. 1 Market research process
• FIG. 2 Data triangulation techniques
• FIG. 3 Primary research pattern
• FIG. 4 Market research approaches
• FIG. 5 Value chain-based sizing & forecasting
• FIG. 6 QFD modeling for market share assessment
• FIG. 7 Market formulation & validation
• FIG. 8 Market outlook, 2021 (USD Billion)
• FIG. 9 Market trends & outlook
• FIG. 10 Market driver relevance analysis (Current & future impact)
• FIG. 11 Market restraint relevance analysis (Current & future impact)
• FIG. 12 Pathology laboratories market: Type movement analysis (USD Billion)
• FIG. 13 Pathology laboratories market Type Segment Dashboard
• FIG. 14 Hospital-Based market, 2017 - 2030 (USD Billion)
• FIG. 15 Standalone labs market 2017 - 2030 (USD Billion)
• FIG. 16 Diagnostic chains market 2017 - 2030 (USD Billion)
• FIG. 17 Pathology laboratories market: Testing Services movement analysis (USD Billion)
• FIG. 18 Pathology laboratories market: Testing services segment dashboard
• FIG. 19 General physiological & clinical tests market, 2017 - 2030 (USD Billion)
• FIG. 20 Imaging & radiology market, 2017 - 2030 (USD Billion)
• FIG. 21 Esoteric tests market, 2017 - 2030 (USD Billion)
• FIG. 22 COVID-19 tests market, 2017 - 2030 (USD Billion)
• FIG. 23 Pathology laboratories market: End-use movement analysis (USD Billion)
• FIG. 24 Pathology laboratories market: End-use segment dashboard
• FIG. 25 Physician referrals market, 2017 - 2030 (USD Billion)
• FIG. 26 Walk-ins market, 2017 - 2030 (USD Billion)
• FIG. 27 Corporate market, 2017 - 2030 (USD Billion)
• FIG. 28 Regional outlook, (USD Billion)
• FIG. 29 Regional market place: Key takeaways
• FIG. 30 North America pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 31 U.S. pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 32 Canada pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 33 Europe pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 34 UK. pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 35 Germany pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 36 France pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 37 Italy pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 38 Spain pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 39 Asia Pacific pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 40 China pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 41 Japan pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 42 India pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 43 South Korea pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 44 Australia pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 45 Latin America pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 46 Brazil pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 47 Mexico pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 48 Argentina pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 49 MEA pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 50 South Africa pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 51 Saudi Arabia pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 52 UAE pathology laboratories market, 2017 - 2030 (USD Billion)
• FIG. 53 Recent developments & impact analysis, by key market participants
• FIG. 54 Company categorization
• FIG. 55 Company market position analysis 

Pathology Laboratories Market Growth & Trends:

The global pathology laboratories market is expected to reach USD 612.2 billion by 2030, based on a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.86% from 2022 to 2030. The major factors driving the industry include increasing life expectancy, the development of healthcare infrastructure in developing nations, favoring reimbursement, and rising demand for routine medical check-ups.

In addition, the advancement of technology is altering the dynamics of diagnosis. Innovative technologies have made Point of Care Testing(POCT) devices portable and improved sampling techniques, making diagnostic services more accessible and efficient. Several advancements are expected to transform the industry by steering patient care through quality, speed, efficiency, and scalability. The healthcare system is progressively emphasizing the importance of pathological & diagnostic labs in becoming a greater clinical decision-making engine, assisting physicians in making inferences and diagnosing as well as monitoring patients more quickly and accurately.

The COVID-19 pandemic has resulted in higher demand for pathology/diagnostic labs as the testing for COVID-19 was necessary during the pandemic. The rapid rise of COVID-19 infections has resulted in increased funding and testing, which has boosted the overall market growth. For instance, the (NIH) National Institutes of Health in the United States announced in September 2020 that it would grant USD 129.3 million in funding to nine organizations including, Maxim Biomedical Inc., MatMaCorp, MicroGEM International, & others, for scaling-up manufacturing assistance to a new set of COVID-19 testing technologies as component of its initiative to boost diagnostics in the region.

Pathology Laboratories Market Report Highlights:

• Based on type, hospital-based diagnostic labs dominated the market during the year 2021. This can be attributed to the advanced tests available at hospitals, making them the only best solution for complex diagnosis

• The imaging & radiology tests segment is expected to have the fastest growth during the forecast period owing to the advancement in imaging techniques & the high prevalence of accidents & target diseases worldwide

• Based on the end use, physician referrals dominated the market in 2021. Walk-in and corporate clients are expected to witness lucrative growth due to increased self-awareness for monitoring health and wellness among individuals

• U.S. is expected to have a high demand for the diagnosis of cardiovascular health as a result of the most prominent disease in the U.S.

• Europe is expected to have a high demand for oncology testing during the forecast period. Denmark has the highest prevalence of cancer globally in terms of cancer prevalence as per the World Cancer Research Fund International

• The market is witnessing multiple collaborations in recent times with the key players aiming at adding value to their services & expanding their research. For Instance, in July 2022, Unilabs announced a partnership with Subtle Medical, to be the first diagnostic company to adopt their AI-based MRI technology for high-quality & quick MRI. The solution will be first launched in Sweden.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Regional Scope
• 1.2 Estimates and Forecast Timeline
• 1.3 Research Methodology
  • 1.3.1 Information procurement
    • 1.3.1.1 Purchased database
    • 1.3.1.2 GVR'S internal database
    • 1.3.1.3 Secondary sources
    • 1.3.1.4 Primary research
    • 1.3.1.4.1 Details of the primary research
• 1.4 Information or Data Analysis
  • 1.4.1 Data Analysis Models
• 1.5 Market Formulation & Validation
• 1.6 Model Details
  • 1.6.1 Commodity Flow Analysis
  • 1.6.2 Volume Price Analysis
• 1.7 List of Secondary Sources
• 1.8 List of Abbreviations
• 1.9 Objectives
  • 1.9.1 Objective - 1
  • 1.9.2 Objective - 2
  • 1.9.3 Objective - 3

Chapter 2 Executive Summary

• 2.1 Market Outlook
• 2.2 Segment Outlook
• 2.3 Regional Outlook
• 2.4 Competitive Insights

Chapter 3 Market Variables, Trends & Scope

• 3.1 Market Dynamics
  • 3.1.1 Market Driver Analysis
    • 3.1.1.1 Improving healthcare infrastructure in developing countries
    • 3.1.1.2 Increasing demand for regular general health check-ups
    • 3.1.1.3 Gowning reimbursement for diagnostics services
  • 3.1.2 Market Restraint Analysis
    • 3.1.2.1 Affordability for high-end molecular diagnostics
    • 3.1.2.2 Shortage of skilled workforce.
• 3.2 Business Environment Analysis Tools
  • 3.2.1 Porter's Five Forces Analysis
    • 3.2.1.1 Threat of new entrants
    • 3.2.1.2 Bargaining power of buyers
    • 3.2.1.3 Competitive rivalry
    • 3.2.1.4 Threat of substitutes
    • 3.2.1.5 Bargaining power of suppliers
• 3.3 Impact of COVID-19
• 3.4 Regulatory Framework & Reimbursement Scenario

Chapter 4 Pathology Laboratories Market: Type Analysis

• 4.1 Pathology Laboratories by Type Market Share Analysis, 2021 & 2030
• 4.2 Segment Dashboard
• 4.3 Market Size and Forecasts and Trend Analysis, 2017 - 2030 for the Type
  • 4.3.1 Hospital Based
    • 4.3.1.1 Hospital-based market, 2017 - 2030 (USD Billion)
  • 4.3.2 Standalone Labs
    • 4.3.2.1 Standalone labs market, 2017 - 2030 (USD Billion)
  • 4.4.3 Diagnostic Chains
    • 4.4.3.1 Diagnostic chains market, 2017 - 2030 (USD Billion)

Chapter 5 Pathology Laboratories Market: Testing Services Analysis

• 5.1 Pathology Laboratories Testing Services Market Share Analysis, 2021 & 2030
• 5.2 Segment Dashboard
• 5.3 Market Size & Forecasts and Trend Analysis, 2017 to 2030 for the Testing Services:
  • 5.3.1 General Physiological & Clinical Tests
    • 5.3.1.1 General physiological & clinical tests market, 2017 - 2030 (USD Billion)
  • 5.3.2 Imaging & Radiology Tests
    • 5.3.2.1 Imaging & radiology tests market, 2017 - 2030 (USD Billion)
  • 5.3.3 Esoteric Tests
    • 5.3.3.1 Esoteric tests market, 2017 - 2030 (USD Billion)
  • 5.3.4 COVID-19 Tests
    • 5.3.4.1 COVID-19 tests market, 2017 - 2030 (USD Billion)

Chapter 6 Pathology Laboratories Market: End-use Analysis

• 6.1 Pathology Laboratories End-use Market Share Analysis, 2021 and 2030
• 6.2 Segment Dashboard
• 6.3 Market Size and Forecasts and Trend Analysis, 2017-2030 for the Following End-Use
  • 6.3.1 Physician Referrals
    • 6.3.1.1 Physician referrals market, 2017 - 2030 (USD Billion)
  • 6.3.2 Walk-Ins
    • 6.3.2.1 Walk-Ins market, 2017 - 2030 (USD Billion)
  • 6.3.3 Corporate
    • 6.3.3.1 Corporate market, 2017 - 2030 (USD Billion)

Chapter 7 Pathology Laboratories Market: Regional Analysis

• 7.1 Pathology Laboratories Regional Market Share Analysis, 2021 & 2030
• 7.2 Regional Market Snapshot (Market Size, CAGR)
• 7.3 Market Size, & Forecasts, and Trend Analysis, 2017 to 2030
  • 7.3.1 North America
    • 7.3.1.1 North America pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.1.2 U.S.
    • 7.3.1.2.1 U.S. pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.1.3 Canada
    • 7.3.1.3.1 Canada pathology laboratories market, 2017 - 2030 (USD Billion)
  • 7.3.2 Europe
    • 7.3.2.1 Europe pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.2.2 U.K.
    • 7.3.2.2.1 UK pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.2.3 Germany
    • 7.3.2.3.1 Germany pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.2.4 France
    • 7.3.2.4.1 France pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.2.5 Italy
    • 7.3.2.5.1 Italy pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.2.6 Spain
    • 7.3.2.6.1 Spain pathology laboratories market, 2017 - 203 (0USD Billion)
  • 7.3.3 Asia Pacific
    • 7.3.3.1 Asia Pacific pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.3.2 Japan
    • 7.3.3.2.1 Japan pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.3.3 China
    • 7.3.3.3.1 China pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.3.4 India
    • 7.3.3.4.1 India pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.3.5 South Korea
    • 7.3.3.5.1 South Korea pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.3.6 Australia
    • 7.3.3.6.1 Australia pathology laboratories market, 2017 - 2030 (USD Billion)
  • 7.3.4 Latin America
    • 7.3.4.1 Latin America pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.4.2 Brazil
    • 7.3.4.2.1 Brazil pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.4.3 Mexico
    • 7.3.4.3.1 Mexico pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.4.4 Argentina
    • 7.3.4.4.1 Argentina pathology laboratories market, 2017 - 2030 (USD Billion)
  • 7.3.5 Middle East and Africa
    • 7.3.5.1 MEA pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.5.2 South Africa
    • 7.3.5.2.1 South Africa pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.5.3 Saudi Arabia
    • 7.3.5.3.1 Saudi Arabia pathology laboratories market, 2017 - 2030 (USD Billion)
    • 7.3.5.4 UAE
    • 7.3.5.4.1 UAE pathology laboratories market, 2017 - 2030 (USD Billion)

Chapter 8 Competitive Analysis

• 8.1 Recent Developments & Impact Analysis, by Key Market Participants
• 8.2 Competition Categorization (Key innovators, Market leaders, Emerging Players)
• 8.3 Company Profiles
  • 8.3.1 Quest Diagnostics Incorporated
    • 8.3.1.1 Company overview
    • 8.3.1.2 Financial performance
    • 8.3.1.3 Service benchmarking
    • 8.3.1.4 Strategic initiatives
  • 8.3.2 Eurofins Scientific
    • 8.3.2.1 Company overview
    • 8.3.2.2 Financial performance
    • 8.3.2.3 Service benchmarking
    • 8.3.2.4 Strategic initiatives
  • 8.3.3 Laboratory Corporation of America Holdings
    • 8.3.3.1 Company overview
    • 8.3.3.2 Financial performance
    • 8.3.3.3 Service benchmarking
    • 8.3.3.4 Strategic initiatives
  • 8.3.4 Exact Sciences Laboratories LLC
    • 8.3.4.1 Company overview
    • 8.3.4.2 Financial performance
    • 8.3.4.3 Service benchmarking
    • 8.3.4.4 Strategic initiatives
  • 8.3.5 Spectra Laboratories
    • 8.3.5.1 Company overview
    • 8.3.5.2 Financial performance
    • 8.3.5.3 Service benchmarking
    • 8.3.5.4 Strategic initiatives
  • 8.3.6 SYNLAB International GmbH
    • 8.3.6.1 Company overview
    • 8.3.6.2 Financial performance
    • 8.3.6.2 Service benchmarking
    • 8.3.6.3 Strategic initiatives
  • 8.3.7 Sonic Healthcare Limited
    • 8.3.7.1 Company overview
    • 8.3.7.2 Financial performance
    • 8.3.7.2 Service benchmarking
    • 8.3.7.3 Strategic initiatives
  • 8.3.8 DR Lal Path Labs.
    • 8.3.8.1 Company overview
    • 8.3.8.2 Financial performance
    • 8.3.8.3 Service benchmarking
    • 8.3.8.4 Strategic initiatives
  • 8.3.9 Metropolis Healthcare
    • 8.3.9.1 Company overview
    • 8.3.8.2 Financial performance
    • 8.3.9.2 Service benchmarking
    • 8.3.9.4 Strategic initiatives
  • 8.3.10 Kingmed Diagnostics
    • 8.3.10.1 Company overview
    • 8.3.10.2 Financial performance
    • 8.3.10.2 Service benchmarking
    • 8.3.10.4 Strategic initiatives
  • 8.3.11 Healius Limited
    • 8.3.11.1 Company overview
    • 8.3.11.2 Financial performance
    • 8.3.11.2 Service benchmarking
    • 8.3.11.4 Strategic initiatives
  • 8.3.12 BioReference
    • 8.3.12.1 Company overview
    • 8.3.12.2 Financial performance
    • 8.3.12.2 Service benchmarking
    • 8.3.12.4 Strategic initiatives
  • 8.3.13 Centro de Diagnosticos
    • 8.3.13.1 Company overview
    • 8.3.13.2 Financial performance
    • 8.3.13.2 Service benchmarking
    • 8.3.13.4 Strategic initiatives
  • 8.3.14 Falco Holdings
    • 8.3.14.1 Company overview
    • 8.3.14.2 Financial performance
    • 8.3.14.2 Service benchmarking
    • 8.3.14.4 Strategic initiatives
  • 8.3.15 Unilabs
    • 8.3.15.1 Company overview
    • 8.3.15.2 Financial performance
    • 8.3.15.2 Service benchmarking
    • 8.3.15.4 Strategic initiatives
• 8.4 Vendor Landscape
  • 8.4.1 Major Deals & Strategic Alliances
  • 8.4.1 Company Market Position Analysis